01/04
Headlines

Chris Lewis

Chris Lewis is Tech Insider's Senior Equity Research analyst covering Internet and Interactive Entertainment. Prior to joining TI in 2011, Chris spent six years at Baird Capital having established the company’s Internet and Video Game research practice. Prior to Wall Street, Chris was a business analyst developing software at Chubb Corporation, and was a co-founder and CFO of Latin American career services website Detacuche.com. Chris appears frequently in the financial and industry press, including CNBC, Bloomberg, CNN, Wall Street Journal, and Financial Times, among others.

Why Trader’s Are Watching: JA Solar Holdings Co., Ltd. (NASDAQ:JASO), ReWalk Robotics (NASDAQ:RWLK), Oracle Corporation (NYSE:ORCL), Parker Drilling (NYSE:PKD), Coronado Biosciences (NASDAQ:CNDO)

Chris Lewis03 mins

Announced Dec 08, Shanghai-based JA Solar Holdings Co., Ltd. (NASDAQ:JASO) announced that it has completed shipping solar modules of 100 megawatts (“MW”) capacity to the first large-scale solar farm in Pakistan. The solar farm, spread across 500 acres, is located within the Quaid-e-Azam Solar Park in Bahawalpur, Pakistan. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) belongs…

Read More

Stocks Gaining Momentum: Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Altria Group Inc. (NYSE:MO), TAL Education Group (NYSE:XRS), Kellogg (NYSE:K)

Chris Lewis02 mins

Brazil’s President Dilma Rousseff said on Monday she has no plans to replace the chief executive officer of state-run oil firm Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A), saying there was no evidence that senior management was involved in a graft scandal at the company. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A) belongs to Basic Materials sector….

Read More

Investors Are Eying: Mobile Telesystems OJSC (NYSE:MBT), TASER International Inc. (NASDAQ:TASR), SeaChange International Inc. (NASDAQ:SEAC), The Spectranetics Corporation (NASDAQ:SPNC), Actuant Corporation (NYSE:ATU)

Chris Lewis03 mins

Mobile TeleSystems OJSC (NYSE:MBT) has been given a consensus recommendation of “Hold” by the nine analysts that are covering the company, American Banking & Market News reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has assigned a buy recommendation to the company….

Read More

Top News: NXP Semiconductors NV (NASDAQ:NXPI), VMware, Inc. (NYSE:VMW), E. I. du Pont de Nemours (NYSE:DD), Toyota Motor (NYSE:TM), HEALTHSOUTH (NYSE:HLS)

Chris Lewis03 mins

NXP Semiconductors NV (NASDAQ:NXPI) was the target of a large decline in short interest during the month of November. As of November 28th, there was short interest totalling 3,134,720 shares, a decline of 36.7% from the November 14th total of 4,953,062 shares, American Banking and Market News reports. NXP Semiconductors NV (NASDAQ:NXPI) belongs to Technology…

Read More

Keep Eyes on: Office Depot, Inc. (NASDAQ:ODP), Pfizer Inc. (NYSE:PFE), L-3 Communications Holdings Inc. (NYSE:LLL), MGP Ingredients Inc. (NASDAQ:MGPI), Xerox Corporation (NYSE:XRX)

Chris Lewis02 mins

BB&T Corp. upgraded shares of Office Depot (NYSE:ODP) from a hold rating to a buy rating in a report released on Tuesday. BB&T Corp. currently has $11.00 price objective on the stock. Office Depot, Inc. (NASDAQ:ODP) belongs to Services sector. Its net profit margin is -2.60% and weekly performance is 11.27%. On last trading day…

Read More

Investors Should Watch: Array BioPharma, Inc. (NASDAQ:ARRY), Comcast Corporation (NASDAQ:CMCSA), Tech Data Corp. (NASDAQ:TECD), Worthington Industries, Inc. (NYSE:WOR), LDR Holding Corporation (NASDAQ:LDRH)

Chris Lewis03 mins

On Dec 12, Oncothyreon Inc. announced that Array BioPharma, Inc. (NASDAQ:ARRY) has granted Oncothyreon an exclusive license to develop, manufacture and commercialize ONT-380 (ARRY-380), an orally active, reversible and selective small molecule HER2 inhibitor. The license agreement replaces the prior Development and Collaboration Agreement under which Oncothyreon and Array were jointly developing ONT-380. Array BioPharma,…

Read More